ConductScience.org, home

Library / Trials

Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy

NCT03809572, Not applicable, Terminated, Oregon Health and Science University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleMindfulness Based Cognitive Therapy (MBCT) During PregnancyClinicalTrials.gov
NCT numberNCT03809572ClinicalTrials.gov
StatusTerminatedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment56 participants, actualClinicalTrials.gov
Lead sponsorOregon Health and Science UniversityClinicalTrials.gov
ConditionsMaternal Psychological Distress, Postpartum Depression, Prenatal StressClinicalTrials.gov
InterventionsMindfulness Based Cognitive TherapyClinicalTrials.gov
First posted2019-01-18ClinicalTrials.gov
Last updated2021-12-20ClinicalTrials.gov

Registered outcomes 9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryCenter for Epidemiologic Studies Depression Scale - Revised (CESD-R)6 Weeks Postpartum
Self-reported depressive symptoms over the past two weeks. There are 20 items, each scored from 0-4. The total score range is from 0-80. Total score will be used, with higher scores indicate more depressive symptoms.
ClinicalTrials.gov
PrimaryEmotion Regulation Questionnaire (ERQ)6 Weeks Postpartum
Self-report of emotion regulation skills. There are two primary subscales, cognitive reappraisal (range: 6-42) and expressive suppression (range: 4-28). Outcome will be total score on the cognitive reappraisal scale. Higher scores for reappraisal indicate better emotion regulation.
ClinicalTrials.gov
PrimaryStroop Task6 Weeks Postpartum
The classic Stroop task is a robust measure of cognitive control. Participants will view a color word in a different color ink, naming the ink color. A control condition is included with neutral words. Interference score will be calculated using reaction times.
ClinicalTrials.gov
PrimaryBrain activation during an emotion regulation task6 Weeks Postpartum
An emotion regulation task will be completed during a functional magnetic resonance imaging (fMRI) scan in order to examine whole-brain functional activation. Individuals will view negative and neutral pictures from the International Affective Picture System. For some pictures, they will just view the images. For some negative pictures, they will be asked to regulate their responding using a distancing technique that has been introduced to them.
ClinicalTrials.gov
PrimaryBrain activation during the Stroop task6 Weeks PostpartumThe Stroop task will be completed during a functional magnetic resonance imaging (fMRI) scan in order to examine whole-brain functional activation when cognitive control must be exerted.ClinicalTrials.gov
SecondaryRate of Postpartum Depression6 Weeks Postpartum, 6 Months Postpartum
Presence of a major depressive episode will be used to determine the presence of postpartum depression. Major depressive episodes will be assessed using the Mood Module of the Structured Clinical Interview for the Diagnostic and Statistical Manual, Fifth Edition (SCID-5).
ClinicalTrials.gov
SecondaryEmotion Regulation Questionnaire (ERQ)6 Months Postpartum
Self-report of emotion regulation skills. There are two primary subscales, cognitive reappraisal (range: 6-42) and expressive suppression (range: 4-28). Outcome will be total score on the cognitive reappraisal scale. Higher scores for reappraisal indicate better emotion regulation.
ClinicalTrials.gov
SecondaryStroop Task6 Months Postpartum
The classic Stroop task is a robust measure of cognitive control. Participants will view a color word in a different color ink, naming the ink color. A control condition is included with neutral words. Interference score will be calculated using reaction times.
ClinicalTrials.gov
SecondaryInfant Behavior Questionnaire - Revised (IBQ-R)6 Months Postpartum
A 193 item self-report measure completed by mothers about specific temperament-related behaviors displayed by their infant over the past two weeks. There are 14 sub-scales derived, each ranging from 0-7. A negative emotionality composite will be derived from the fear, sadness, and distress to limitations sub-scales.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
26654212BACKGROUNDPubMed

Grants 1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource
R21AT010292Mechanisms of Action of MBCT-PD: A Pilot StudyMACKIEWICZ SEGHETE, KRISTEN LOREGON HEALTH & SCIENCE UNIVERSITYNATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH2018 to 2019NIH RePORTER

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Emotion Regulation TaskPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)